Health Care

Zoetis Inc Celebrates a Decade of Dominance with Skyrocketing Stock Value Amid Global Trade Challenges

Zoetis Inc has dominated the animal health market for a decade, with its stock value increasing 200% to over $66 billion, but faces challenges from tariffs and trade wars.

Vanessa Liu

01/08/2025, 13:31

2 minutes to read

Revvity Inc Stock Price Falls Amid Market Adjustments and Growth Prospects in Molecular Diagnostics

Revvity Inc’s stock price has declined to $90.61 per share due to analyst price target adjustments and headwinds from China.

Elliot Mercer

01/08/2025, 13:10

One minute to read

Pro Medicus Ltd’s Stock Soars 42% Following Strategic Investment in 4DMedical

Pro Medicus Ltd’s stock price has surged 42% following a $10 million investment in medical imaging company 4DMedical.

Elliot Mercer

01/08/2025, 12:57

One minute to read

Amgen Set to Release Q2 Financials Amid Market Challenges and Growth Opportunities in Biotech

Amgen is set to release its second quarter financial results on August 5, 2025, amidst market leading artists, and the theme parkour Street characters. 2 Date: 2025/07-07T00:55:00.000Z Source: www.finanews.com

Sands China’s shares price-Part of Ex…

Jake Connors

01/08/2025, 12:51

2 minutes to read

Takeda Reports 8.39% Sales Decline Amid Strong R&D Focus

Takeda Pharmaceutical Co Ltd reported an 8.39% decline in sales and a decrease in earnings per share, but maintains strong long-term prospects driven by research and development in key areas.

Elliot Mercer

01/08/2025, 12:28

One minute to read

Novartis Celebrates FDA Approval for Leqvio Amid Trump’s Price Pressure Concerns

Novartis receives FDA approval for its medication Leqvio, but its stock price is impacted by US President Trump’s demands for lower medication prices.

Vanessa Liu

01/08/2025, 11:57

2 minutes to read

Eisai’s LEQEMBI(R) Revolutionizes Alzheimer’s Treatment with Promising Clinical Results and Revenue Growth

Eisai’s LEQEMBI(R) treatment for Alzheimer’s disease has shown significant progress, with strong sales and new clinical data highlighting its effectiveness in slowing disease progression.

Jake Connors

01/08/2025, 11:51

2 minutes to read

Otsuka Holdings Soars in Earnings, But Can It Maintain Its Flight?

Otsuka Holdings Co., Ltd. reports strong first half earnings, but investors should exercise caution and carefully evaluate the company’s financials to determine if the momentum can be sustained.

Vanessa Liu

01/08/2025, 11:49

2 minutes to read

Labcorp Revolutionizes Healthcare with AI Tool and EU Milestone in Personalized Cancer Care

Labcorp is leading the charge in healthcare innovation with the introduction of its AI-powered Test Finder tool and achievement of IVDR CE-Marking for PGDx elio, expanding access to personalized cancer care.

Vanessa Liu

01/08/2025, 11:43

2 minutes to read

QIAGEN NV Stock Rises on Positive Analyst Outlook and Molecular Diagnostics Growth

QIAGEN NV’s stock price has seen a moderate increase due to analysts’ optimistic views on the company’s prospects in the growing molecular diagnostics market.

Elliot Mercer

01/08/2025, 09:52

One minute to read